29
/fr/
fr
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
Créer
Public Timelines
Bibliothèque
FAQ
For education
Cabinet
For educational institutions
For teachers
For students/pupils
Télécharger
Export
Créer une copie
Intégrer dans le site Web
Éditer
Les affichages 283
0
0
IRD trials box
A été creé
Jason Comander
⟶ mise à jour avec succès 2 févr. 2020 ⟶
List of edits
Commentaires
Les événements
Vitamin A/E for Retinitis Pigmentosa
Omega-3 (DHA) for Retinitis Pigmentosa
Lutein for Retinitis Pigmentosa
Safety and Dose Escalation Study of AAV2-hCHM in Subjects With CHM (Choroideremia) Gene Mutations
Safety and Efficacy of rAAV-hRS1in Patients With X-linked Retinoschisis (XLRS)
Safety and Tolerability of hRPC in Retinitis Pigmentosa
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia
Rate of Progression in USH2A Related Retinal Degeneration (RUSH 2A)
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia
Gene Therapy for X-linked RP (RPGR)
Ocular Genomics Institute created
AAV platform technology enters in strategic partnership with Lonza
Odylia Therapeutics is founded
First post-approval gene therapy procedure for an inherited disease (voretigene/RPE65)
First DNA mutation identified for an inherited retinal degeneration
Founding of Berman-Gund Laboratory & RP Foundation
A Safety Study of Retinal Gene Therapy for Choroideremia (GEMINI)
Single Ascending Dose Study in Participants With LCA10 (CEP290 / CRISPR)